Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

The effect of platelet storage temperature on haemostatic, immune, and endothelial function: potential for personalised medicine.

Shea SM, Thomas KA, Spinella PC.

Blood Transfus. 2019 Jul;17(4):321-330. doi: 10.2450/2019.0095-19. Review.

2.

Noninvasive Monitoring of Allogeneic Stem Cell Delivery with Dual-Modality Imaging-Visible Microcapsules in a Rabbit Model of Peripheral Arterial Disease.

Fu Y, Weiss CR, Kedziorek DA, Xie Y, Tully E, Shea SM, Solaiyappan M, Ehtiati T, Gabrielson K, Wacker FH, Bulte JWM, Kraitchman DL.

Stem Cells Int. 2019 Mar 14;2019:9732319. doi: 10.1155/2019/9732319. eCollection 2019.

3.

Effect of leukoreduction and pathogen reduction on the hemostatic function of whole blood.

Thomas KA, Shea SM, Yazer MH, Spinella PC.

Transfusion. 2019 Apr;59(S2):1539-1548. doi: 10.1111/trf.15175.

PMID:
30980757
4.

Quantitative CT and 19F-MRI tracking of perfluorinated encapsulated mesenchymal stem cells to assess graft immunorejection.

Wang G, Fu Y, Shea SM, Hegde SS, Kraitchman DL.

MAGMA. 2019 Feb;32(1):147-156. doi: 10.1007/s10334-018-0728-2. Epub 2018 Dec 10.

PMID:
30535540
5.

Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?

Harkenrider MM, Patel R, Surucu M, Chinsky B, Mysz ML, Wood A, Ryan K, Shea SM, Small W Jr, Roeske JC.

Brachytherapy. 2018 Sep - Oct;17(5):747-752. doi: 10.1016/j.brachy.2018.05.010. Epub 2018 Jun 23.

PMID:
29945764
6.

Providing MR Imaging for Cervical Cancer Brachytherapy: Lessons for Radiologists.

Sullivan T, Yacoub JH, Harkenrider MM, Small W Jr, Surucu M, Shea SM.

Radiographics. 2018 May-Jun;38(3):932-944. doi: 10.1148/rg.2018170033. Review.

PMID:
29757719
7.

Simultaneous tumor and surrogate motion tracking with dynamic MRI for radiation therapy planning.

Park S, Farah R, Shea SM, Tryggestad E, Hales R, Lee J.

Phys Med Biol. 2018 Jan 11;63(2):025015. doi: 10.1088/1361-6560/aaa20b.

8.

Reduction of MRI signal distortion from titanium intracavitary brachytherapy applicator by optimizing pulse sequence parameters.

Sullivan TP, Harkenrider MM, Surucu M, Wood AM, Yacoub JH, Shea SM.

Brachytherapy. 2018 Mar - Apr;17(2):377-382. doi: 10.1016/j.brachy.2017.10.013. Epub 2017 Nov 22.

PMID:
29174384
9.

Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.

Harkenrider MM, Surucu M, Harmon G, Mysz ML, Shea SM, Yacoub J, Goldberg A, Liotta M, Winder A, Potkul R, Roeske JC, Small W Jr.

Brachytherapy. 2018 Jan - Feb;17(1):187-193. doi: 10.1016/j.brachy.2017.09.010. Epub 2017 Oct 28.

PMID:
29089277
10.

Evaluation of lung tumor motion management in radiation therapy with dynamic MRI.

Park S, Farah R, Shea SM, Tryggestad E, Hales R, Lee J.

Proc SPIE Int Soc Opt Eng. 2017 Feb 11;10135. pii: 101351R. doi: 10.1117/12.2254676. Epub 2017 Mar 3.

11.

How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer.

Harkenrider MM, Shea SM, Wood AM, Chinsky B, Bajaj A, Mysz M, Yacoub JH, Goldberg A, Liotta M, Potkul R, Surucu M, Roeske J, Small W Jr.

J Contemp Brachytherapy. 2017 Apr;9(2):177-186. doi: 10.5114/jcb.2017.66892. Epub 2017 Mar 30. Review.

12.

Spectral characterization of tissues in high spectral and spatial resolution MR images: Implications for a classification-based synthetic CT algorithm.

Wood AM, Shea SM, Medved M, Karczmar GS, Surucu M, Gros S, Small W Jr, Roeske J.

Med Phys. 2017 May;44(5):1865-1875. doi: 10.1002/mp.12173. Epub 2017 Apr 13.

PMID:
28236649
13.

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.

Salerno EP, Bedognetti D, Mauldin IS, Deacon DH, Shea SM, Pinczewski J, Obeid JM, Coukos G, Wang E, Gajewski TF, Marincola FM, Slingluff CL Jr.

Oncoimmunology. 2016 Oct 18;5(12):e1240857. doi: 10.1080/2162402X.2016.1240857. eCollection 2016.

14.

Point A vs. HR-CTV D90 in MRI-based cervical brachytherapy of small and large lesions.

Harmon G, Diak A, Shea SM, Yacoub JH, Small W Jr, Harkenrider MM.

Brachytherapy. 2016 Nov - Dec;15(6):825-831. doi: 10.1016/j.brachy.2016.08.010. Epub 2016 Sep 29.

PMID:
27693173
15.

Evaluation of Left Ventricular Outflow Tract Obstruction With Four-Dimensional Phase Contrast Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy-A Pilot Study.

Chu LC, Porter KK, Corona-Villalobos CP, Gülsün MA, Shea SM, Markl M, Abraham TP, Bluemke DA, Kamel IR, Zimmerman SL.

J Comput Assist Tomogr. 2016 Nov/Dec;40(6):937-940.

PMID:
27529682
16.

The role of capsaicin in dermatology.

Boyd K, Shea SM, Patterson JW.

Prog Drug Res. 2014;68:293-306. Review.

PMID:
24941674
17.

Measurement accuracy of different active tracking sequences for interventional MRI.

Wech T, Shea SM, Barbot J, Vij K, Pan L, Lorenz CH, Patil S.

J Magn Reson Imaging. 2014 Aug;40(2):490-5. doi: 10.1002/jmri.24374. Epub 2013 Oct 31.

PMID:
24677517
18.

Using C-arm x-ray imaging to guide local reporter probe delivery for tracking stem cell engraftment.

Kedziorek DA, Solaiyappan M, Walczak P, Ehtiati T, Fu Y, Bulte JW, Shea SM, Brost A, Wacker FK, Kraitchman DL.

Theranostics. 2013 Dec 17;3(11):916-26. doi: 10.7150/thno.6943. eCollection 2013.

19.

Image corruption detection in diffusion tensor imaging for post-processing and real-time monitoring.

Li Y, Shea SM, Lorenz CH, Jiang H, Chou MC, Mori S.

PLoS One. 2013 Oct 25;8(10):e49764. doi: 10.1371/journal.pone.0049764. eCollection 2013.

20.

4D tumor centroid tracking using orthogonal 2D dynamic MRI: implications for radiotherapy planning.

Tryggestad E, Flammang A, Hales R, Herman J, Lee J, McNutt T, Roland T, Shea SM, Wong J.

Med Phys. 2013 Sep;40(9):091712. doi: 10.1118/1.4818656.

PMID:
24007145
21.

Cutaneous side effects of vemurafenib: a case report and discussion.

Shea SM, Boyd K, Patterson J.

Wien Med Wochenschr. 2013 Aug;163(15-16):376-9. doi: 10.1007/s10354-013-0217-1. Epub 2013 Jul 4.

PMID:
23824179
22.

Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipients.

Boyd K, Shea SM, Patterson J.

Wien Med Wochenschr. 2013 Aug;163(15-16):372-5. doi: 10.1007/s10354-013-0213-5. Epub 2013 Jun 26. Review.

PMID:
23800851
23.

Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptide.

Salerno EP, Shea SM, Olson WC, Petroni GR, Smolkin ME, McSkimming C, Chianese-Bullock KA, Slingluff CL Jr.

Cancer Immunol Immunother. 2013 Jul;62(7):1149-59. doi: 10.1007/s00262-013-1435-5. Epub 2013 May 9.

24.

Respiration-based sorting of dynamic MRI to derive representative 4D-MRI for radiotherapy planning.

Tryggestad E, Flammang A, Han-Oh S, Hales R, Herman J, McNutt T, Roland T, Shea SM, Wong J.

Med Phys. 2013 May;40(5):051909. doi: 10.1118/1.4800808.

PMID:
23635279
25.

Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).

Slingluff CL Jr, Petroni GR, Molhoek KR, Brautigan DL, Chianese-Bullock KA, Shada AL, Smolkin ME, Olson WC, Gaucher A, Chase CM, Grosh WW, Weiss GR, Wagenseller AG, Olszanski AJ, Martin L, Shea SM, Erdag G, Ram P, Gershenwald JE, Weber MJ.

Clin Cancer Res. 2013 Jul 1;19(13):3611-20. doi: 10.1158/1078-0432.CCR-12-3919. Epub 2013 Apr 25.

26.

Short-term application of doxorubicin chemotherapy immunosuppressive side effects for composite tissue allotransplantation.

Hui-Chou HG, Olenczak JB, Drachenberg CB, Shea SM, Rodriguez ED.

Ann Plast Surg. 2012 Feb;68(2):215-21. doi: 10.1097/SAP.0b013e3182467f7b.

PMID:
22270570
27.

Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.

Erdag G, Schaefer JT, Smolkin ME, Deacon DH, Shea SM, Dengel LT, Patterson JW, Slingluff CL Jr.

Cancer Res. 2012 Mar 1;72(5):1070-80. doi: 10.1158/0008-5472.CAN-11-3218. Epub 2012 Jan 19.

28.

A new approach towards improved visualization of myocardial edema using T2-weighted imaging: a cardiovascular magnetic resonance (CMR) study.

Cocker MS, Shea SM, Strohm O, Green J, Abdel-Aty H, Friedrich MG.

J Magn Reson Imaging. 2011 Aug;34(2):286-92. doi: 10.1002/jmri.22622.

PMID:
21780224
29.

High inter-rater reliability in analyzing results of decomposition-based quantitative electromyography in subjects with or without neuromuscular disorder.

Boe SG, Antonowicz NM, Leung VW, Shea SM, Zimmerman TC, Doherty TJ.

J Neurosci Methods. 2010 Sep 30;192(1):138-45. doi: 10.1016/j.jneumeth.2010.07.024. Epub 2010 Jul 30.

PMID:
20674605
30.

Improvements in the staging of cutaneous squamous-cell carcinoma in the 7th edition of the AJCC Cancer Staging Manual.

Lardaro T, Shea SM, Sharfman W, Liégeois N, Sober AJ.

Ann Surg Oncol. 2010 Aug;17(8):1979-80. doi: 10.1245/s10434-010-1009-0. No abstract available.

PMID:
20490700
31.

Comprehensive adenosine stress perfusion MRI defines the etiology of chest pain in the emergency room: Comparison with nuclear stress test.

Vogel-Claussen J, Skrok J, Dombroski D, Shea SM, Shapiro EP, Bohlman M, Lorenz CH, Lima JA, Bluemke DA.

J Magn Reson Imaging. 2009 Oct;30(4):753-62. doi: 10.1002/jmri.21899.

32.

Axial black blood turbo spin echo imaging of the right ventricle.

Berkowitz SJ, Macedo R, Malayeri AA, Shea SM, Lorenz CH, Calkins H, Vogel-Claussen J, Tandri H, Bluemke DA.

Magn Reson Med. 2009 Feb;61(2):307-14. doi: 10.1002/mrm.21864.

33.

Three-dimensional breathhold magnetization-prepared TrueFISP: a pilot study for magnetic resonance imaging of the coronary artery disease.

McCarthy RM, Deshpande VS, Beohar N, Meyers SN, Shea SM, Green JD, Liu X, Bi X, Pereles FS, Finn JP, Davidson CJ, Carr JC, Li D.

Invest Radiol. 2007 Oct;42(10):665-70.

34.

Coronary magnetic resonance angiography using magnetization-prepared contrast-enhanced breath-hold volume-targeted imaging (MPCE-VCATS).

Yang CW, Carr JC, Francois CJ, Shea SM, Deshpande VS, Meyers SN, Beohar N, Finn JP, Li D.

Invest Radiol. 2006 Aug;41(8):639-44.

PMID:
16829747
35.

Coronary artery anomalies diagnosed by magnetic resonance angiography.

Welker M, Salanitri J, Deshpande VS, Shea SM, Li D, Pereles FS.

Australas Radiol. 2006 Apr;50(2):114-21. Review.

PMID:
16635028
36.

T2-prepared steady-state free precession blood oxygen level-dependent MR imaging of myocardial perfusion in a dog stenosis model.

Shea SM, Fieno DS, Schirf BE, Bi X, Huang J, Omary RA, Li D.

Radiology. 2005 Aug;236(2):503-9.

PMID:
16040907
37.

Accurate myocardial T1 measurements: toward quantification of myocardial blood flow with arterial spin labeling.

Zhang H, Shea SM, Park V, Li D, Woodard PK, Gropler RJ, Zheng J.

Magn Reson Med. 2005 May;53(5):1135-42.

38.

Catheter-directed MR angiography and cross-sectional imaging for the assessment of renal artery stenosis.

Omary RA, Schirf BE, Green JD, Kanwar YS, Shea SM, Carroll TJ, Carr J, Li D.

J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):255-60.

PMID:
15713927
39.

Myocardial perfusion imaging based on the blood oxygen level-dependent effect using T2-prepared steady-state free-precession magnetic resonance imaging.

Fieno DS, Shea SM, Li Y, Harris KR, Finn JP, Li D.

Circulation. 2004 Sep 7;110(10):1284-90. Epub 2004 Aug 23.

PMID:
15326062
40.

Coronary artery imaging using three-dimensional breath-hold steady-state free precession with two-dimensional iterative partial fourier reconstruction.

Singh RK, Deshpande VS, Haacke EM, Shea SM, Xu Y, McCarthy RM, Carr J, Li D.

J Magn Reson Imaging. 2004 May;19(5):645-9.

PMID:
15112316
41.
42.

Coronary MR angiography: true FISP imaging improved by prolonging breath holds with preoxygenation in healthy volunteers.

McCarthy RM, Shea SM, Deshpande VS, Green JD, Pereles FS, Carr JC, Finn JP, Li D.

Radiology. 2003 Apr;227(1):283-8. Epub 2003 Feb 28.

PMID:
12616011
43.

Reduction of transient signal oscillations in true-FISP using a linear flip angle series magnetization preparation.

Deshpande VS, Chung YC, Zhang Q, Shea SM, Li D.

Magn Reson Med. 2003 Jan;49(1):151-7.

44.

Three-dimensional true-FISP imaging of the coronary arteries: improved contrast with T2-preparation.

Shea SM, Deshpande VS, Chung YC, Li D.

J Magn Reson Imaging. 2002 May;15(5):597-602.

PMID:
11997902
45.

Breath-hold three-dimensional true-FISP imaging of coronary arteries using asymmetric sampling.

Deshpande VS, Shea SM, Chung YC, McCarthy RM, Finn JP, Li D.

J Magn Reson Imaging. 2002 Apr;15(4):473-8.

PMID:
11948838
46.

3D magnetization-prepared true-FISP: a new technique for imaging coronary arteries.

Deshpande VS, Shea SM, Laub G, Simonetti OP, Finn JP, Li D.

Magn Reson Med. 2001 Sep;46(3):494-502.

47.

Coronary artery imaging using contrast-enhanced 3D segmented EPI.

Deshpande VS, Wielopolski PA, Shea SM, Carr J, Zheng J, Li D.

J Magn Reson Imaging. 2001 May;13(5):676-81.

PMID:
11329188
48.

Coronary arteries: magnetization-prepared contrast-enhanced three-dimensional volume-targeted breath-hold MR angiography.

Li D, Carr JC, Shea SM, Zheng J, Deshpande VS, Wielopolski PA, Finn JP.

Radiology. 2001 Apr;219(1):270-7.

PMID:
11274569
49.

Coronary artery imaging: 3D segmented k-space data acquisition with multiple breath-holds and real-time slab following.

Shea SM, Kroeker RM, Deshpande V, Laub G, Zheng J, Finn JP, Li D.

J Magn Reson Imaging. 2001 Feb;13(2):301-7.

PMID:
11169838
50.

Compensatory growth of glomeruli.

Shea SM.

Lab Invest. 1994 Dec;71(6):918. No abstract available.

PMID:
7807974

Supplemental Content

Support Center